Literature DB >> 1566951

Carrier screening for cystic fibrosis: a pilot study of the attitudes of pregnant women.

J R Botkin1, S Alemagno.   

Abstract

We surveyed the attitudes of a consecutive sample of 306 pregnant Caucasian women toward carrier screening for cystic fibrosis. Of the 214 respondents, 98% said that screening should be offered before pregnancy, and 69% said they would accept carrier screening during pregnancy. Twenty-nine percent of the respondents indicated a willingness to terminate a pregnancy if the fetus were found to have cystic fibrosis. We conclude that carrier screening is of interest to pregnant women, although interest in terminating a pregnancy because of screening results may be limited.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1992        PMID: 1566951      PMCID: PMC1694124          DOI: 10.2105/ajph.82.5.723

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  17 in total

1.  The cystic fibrosis gene: medical and social implications for heterozygote detection.

Authors:  Benjamin S Wilfond; Norman Fost
Journal:  JAMA       Date:  1990 May 23-30       Impact factor: 56.272

2.  Cystic fibrosis pilot projects go begging.

Authors:  L Roberts
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

3.  Screening for cystic fibrosis; public policy and personal choices.

Authors:  H R Colten
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

4.  To test or not to test?

Authors:  L Roberts
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

5.  The American Society of Human Genetics statement on cystic fibrosis screening.

Authors:  C T Caskey; M M Kaback; A L Beaudet
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

6.  A cluster of highly polymorphic dinucleotide repeats in intron 17b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; D Markiewicz; F Rininsland; J Rommens; L C Tsui
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

7.  Health behavior and genetic screening for carriers of Tay-Sachs disease: a prospective study.

Authors:  M S Goldstein; S Greenwald; T Nathan; F Massarik; M M Kaback
Journal:  Soc Sci Med       Date:  1977-05       Impact factor: 4.634

8.  Assessment of risk by pregnant women: implications for genetic counseling and education.

Authors:  G A Chase; R R Faden; N A Holtzman; A J Chwalow; C O Leonard; C Lopes; K Quaid
Journal:  Soc Biol       Date:  1986 Spring-Summer

9.  Utilization of prenatal genetic diagnosis in women 35 years of age and older in the United States, 1977 to 1978.

Authors:  M M Adams; S Finley; H Hansen; R I Jahiel; G P Oakley; W Sanger; G Wells; W Wertelecki
Journal:  Am J Obstet Gynecol       Date:  1981-03-15       Impact factor: 8.661

10.  Acceptance of amniocentesis by low-income patients in an urban hospital.

Authors:  J P Marion; G Kassam; P M Fernhoff; K E Brantley; L Carroll; J Zacharias; L Klein; J H Priest; L J Elsas
Journal:  Am J Obstet Gynecol       Date:  1980-09-01       Impact factor: 8.661

View more
  14 in total

1.  Cystic fibrosis genotypes and views on screening are both heterogeneous and population related.

Authors:  C R Scriver; T M Fujiwara
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

2.  Carrier screening in preconception consultation in primary care.

Authors:  Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2011-12-20

3.  A comparison of two approaches to education about carrier testing for cystic fibrosis.

Authors:  K P Leonard; L K Bartholomew; P R Swank; G S Parcel
Journal:  J Genet Couns       Date:  1995-06       Impact factor: 2.537

4.  Costs, effects, and savings of screening for cystic fibrosis gene carriers.

Authors:  M F Wildhagen; H B Hilderink; J G Verzijl; J B Verheij; L Kooij; T Tijmstra; L P ten Kate; J D Habbema
Journal:  J Epidemiol Community Health       Date:  1998-07       Impact factor: 3.710

5.  Genetic screening for reproductive planning: methodological and conceptual issues in policy analysis.

Authors:  D A Asch; J C Hershey; M V Pauly; J P Patton; M K Jedrziewski; M T Mennuti
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

6.  "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.

Authors:  Liane Ioannou; Martin B Delatycki; John Massie; Jan Hodgson; Sharon Lewis
Journal:  J Genet Couns       Date:  2015-05-01       Impact factor: 2.537

7.  Nonparticipation in Huntington's Disease Predictive Testing: Reasons for Caution in Interpreting Findings.

Authors:  J Binedell; J R Soldan
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

8.  Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome.

Authors:  M Godfrey; N Vandemark; M Wang; M Velinov; D Wargowski; P Tsipouras; J Han; J Becker; W Robertson; S Droste
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

9.  Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening.

Authors:  E W Clayton; V L Hannig; J P Pfotenhauer; R A Parker; P W Campbell; J A Phillips
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

10.  Cystic fibrosis heterozygote screening in 5,161 pregnant women.

Authors:  D R Witt; C Schaefer; P Hallam; S Wi; B Blumberg; A Fishbach; J Holtzman; S Kornfeld; R Lee; L Nemzer; R Palmer
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.